Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin alfa for Anemia in Cancer Patients on Non-Platinum Chemo
NCT00270127Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Aug 1996
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 3 trial of epoetin alfa in anemia, sponsored by Johnson & Johnson. Started Aug 1996; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00270127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00270127.